lb cv feb 2019 - derm.net fileleslie s. baumann md academic non-academic departmental administrative...

Curriculum Vitae

PERSONAL

HIGHER EDUCATION

Name: Leslie Stafford Baumann, MD, CPI

Office Phone: 305-532-5552

Office Address: Baumann Cosmetic and Research Institute 4500 Biscayne Blvd. Suites 105 and 101 Miami, Florida 33137

Email: [email protected]

Citizenship: USA

Languages: English Spanish – working knowledge

July 1994 – June 1997 Residency Department of Dermatology and Cutaneous Surgery University of Miami School of Medicine, Miami, FL

July 1993 – June 1994 Internship Department of Pediatrics Baylor College of Medicine, Houston, TX

mailto:[email protected]

Leslie S. Baumann MD

BOARD CERTIFICATION

LICENSURE & CERTIFICATION

EXPERIENCE

July 1989 – May 1993 Doctor of Medicine Baylor College of Medicine, Houston, TX

May 1989 Bachelor of Arts, Biology The University of Texas, Austin, TX

September 1997 – present American Board of Dermatology (recertification September 2018)

May 1994 – present Texas License number J6326

May 1997 – present Florida License number ME72961

September 2003 – present New York License number 229865

August 2006 – present California License number C52472

March 2005 – present Certified Physician Investigator (CPI), Association of Clinical Research Professionals (ACRP) (recertification April 2007)

Page ! of !2 50


Academic

Non-Academic

DEPARTMENTAL ADMINISTRATIVE & COMMITTEE RESPONSIBILITIES

February 2008 – October 2009 Director, Cosmetic Medicine and Research Institute Professor of Clinical Dermatology Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine

June 2006 – January 2008 Professor of Clinical Dermatology Director, Division of Cosmetic Dermatology Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine

June 2003 – May 2006 Associate Professor of Clinical Dermatology Director, Division of Cosmetic Dermatology Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine

July 1997 – May 2003 Assistant Professor of Clinical Dermatology Director of Cosmetic Dermatology Department of Dermatology and Cutaneous Surgery University of Miami School of Medicine

Baumann Cosmetic and Research Institute Chief Executive Officer

Student Member, Liver Transplantation Team Michael E. DeBakey Summer Surgery Program Baylor College of Medicine, Houston, Texas

Page ! of !3 50


PUBLICATIONS

Textbook

Consumer Book

Textbook Chapters

2005-2009

July 1997 – 2005

Chairman, Cosmetic Medicine & Research Institute University of Miami School of Medicine

Director and Chief, Division of Cosmetic Dermatology Department of Dermatology University of Miami School of Medicine

Baumann L. Cosmeceuticals and Cosmetic Ingredients. New York McGraw-Hill, 2014 Baumann L. Cosmetic Dermatology: Principles and Practices, Second Edition. New York

McGraw-Hill, 2009.

Baumann L. Cosmetic Dermatology: Principles and Practices. New York McGraw-Hill, 2002. Published in English, Turkish, Portuguese and Korean.

Baumann L. The Skin Type Solution (paperback). New York: Bantam, 2006.

Baumann L. The Skin Type Solution. New York: Bantam, 2005.

Baumann L. The Skin Type Solution. Sydney: Penguin, 2005.

Baumann L. The Skin Type Solution. London: Hodder & Stoughton, 2005.

Page ! of !4 50


1. Baumann, L., “How to Use Oral and Topical Cosmeceu<cals to Prevent and Treat Skin Aging.” Facial Plas)c Surgery Clinics of North American 2018 November 407-413

2. Baumann L. “How to Use Oral and Topical Cosmeceu<cals to Prevent and Test Skin Aging,” in Current U<liza<on of Biologicals, Keller, G.S., Thomas, J.R., pp. 407-413

3. Baumann L. “Nonsurgical skin care and reguventa<on,” in Plas<c Surgery, Third Edi<on, P.C., Neligan, R.J., Warren, pp. 13-29

4. Baumann L. “The Baumann Skin Typing System,” in Textbook of Aging Skin, Vol 3, In Farage, M.A., Miller, K.W., Maibach, H.I.; Springer-Verlag Berlin Heidelberg, pp. 1579-1597

5. Baumann L. “Op<mizing Outcome from Facial Cosme<c Injec<ons and Promo<ng Realis<c Expecta<ons,” in Pearls and Pi`alls in Cosme<c Oculoplas<c Surgery, Second Edi<on, Morris E. Hartstein, Guy G. Massry, John B. Holds; Springer, pp.459-462.

6. Baumann L. “The Baumann Skin-Type Indicator: A Novel Approach to Understanding Skin Type,” in Handbook of Cosme<c Science and Technology, Third Edi<on, Ed Andre O. Barel, Marc Paye and Howard I. Maibach; Informa Healthcare, pp. 29-40.

7. Baumann L. “The Baumann Skin Typing System,” in Textbook of Aging Skin, Ed. Miranda A. Farage, Kenneth W. Miller, Howard I. Maibach; Springer, pp. 929-944.

8. Baumann L, Weisberg E. “Olive Oil in Botanical Cosmeceu<cals,” in Olives and Olive Oil in Health and Disease Preven<on, Ed. Victor R. Preedy and Ronald Ross Watson; Oxford:Academic Press, pp. 1117-1124.

9. Baumann L, Mar<n LK. “Skin Whitening: New Hydroquinone Combina<on,” in Handbook of Cosme<c Science and Technology, Second Edi<on, Ed. M. Paye; New York: Marcel Dekker, Inc., Accepted for Publica<on, pp. 319-325.

10. Baumann L. “Op<mizing Outcome from Facial Cosme<c Injec<ons and Promo<ng Realis<c Expecta<ons,” in Pearls and Pi`alls, Ed. Hartstein et. al., Accepted for Publica<on.

11. Baumann L. “Cosme<cs and Skin Care in Dermatology,” in Fitzpatrick’s Dermatology in General Medicine, Ed. K. Wolff et. al.; New York: McGraw-Hill, 2008, pp. 2357-2364.

12. Kaufman J, Baumann L. “Hyperhydrosis,” in Therapeu<c Uses of Botulinum Toxin, Ed. G. Cooper; Totowa NJ: Humana Press, 2007, pp. 153-166.

13. Benjamin LT, Alvarez Connelly E, Baumann L, Schachner LA. “Sun Protec<on in the Pediatric Pa<ent,” in Current Pediatric Therapy-18th Edi<on, Ed. FD Burg, JR Ingelfinger, RA Polin, and AA Gershon; Philadelphia: Saunders Elsevier, 2006, pp. 1091-1093.

14. Baumann L, Vujevich J. “Permanent Fillers”, in Techniques in Dermatologic Surgery, Ed. K. Nouri and S. Leal-Khouri, Elsevier Ltd, 2003, pp. 293-296.

15. Baumann L, Machado C, Lazarus M, Kerdel F. “The Status of An<viral Drugs for Skin Disorders”, in Dermatologic Therapy in Current Prac<ce, Ed. R Marks and JJ Leyden; Mar<n Dunitz, Inc, 2002, pp. 177-198.

Page ! of !5 50


16. Baumann L, Daza I, Lourenco AC, Lazarus M. “Cosme<c Dermatology”, in Dermatologic Therapy in Current Prac<ce, Ed. R Marks and JJ Leyden; Mar<n Dunitz, Inc, 2002, pp. 229-251.

17. Baumann L, Schachner L, Lazarus M.. “Sun Protec<on in the Pediatric Popula<on”, Gellis and Kagan’s Current Pediatric Therapy, ed. Burg, Ingelfinger, Wald and Polin, 17th Edi<on, 2002. pp. 896-897

18. Barba A, Baumann L. “Nonlaser Hair Removal Techniques”, James WD, Elston D (Chief Eds.); eMedicine: Dermatology. St. Petersburg: eMedicine Corpora<on, 2000.

19. Baumann L, Schachner L. “Sun Protec<on in the Pediatric Popula<on”, Gellis and Kagan’s Current Pediatric Therapy ed. Burg, Ingelfinger, Wald and Polin, 16th Ed. pp. 998-999.

20. Baumann L, Kerdel F. Chapter 243, “Topical Cor<costeroids”, 5th Edi<on text, Fitzpatrick, Dermatology in General Medicine, pp. 2713-2717.

21. Baumann L, Schachner L. “Sun Protec<on in the Pediatric Popula<on”, Gellis and Kagan’s Current Pediatric Therapy ed. Burg, Ingelfinger, Wald and Polin, 15th Ed.

Peer Reviewed Journals

Page ! of !6 50


Baumann, L.S., Shridharani, S.M., Humphrey, S., Gallagher, C.J., “Personal (Self) Perceptions of Submental Fat Among Adults in the United States” Dermatologic Surgery 2019 January; 45|1- p124-130

Baumann, L.S., Weisberg, E.M., Mayans, M., Arcuri, E., “Open Label Study Evaluating Efficacy, Safety, and Effects on Perception of Age After Injectable 20mg/ mL Hyaluronic Acid Gel for Volumization of Facial Temples” Journal of Drugs in Dermatology 2019 January 18|1|Pages 723-730

Baumann, L., Blauvelt, A., Draelos, Z., Kempers, S., Lupo, M., Schlessinger, J., & Shanler, S. D. (2018). 465 “A-101 (hydrogen peroxide) topical solution safety and efficacy in patients with seborrheic keratoses: Results from two identical randomized, double-blind, placebo-controlled, phase 3 studies.” Journal of Investigative Dermatology, 138(5), S79.

Baumann, L.S., Blauvelt, A., Draelos, Z.D., Kempers, E.E., Lupo, M.P., Schlessginer, J., Shanler, S.D. “Safety and efficacy of hydrogen peroxide topical solutions, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302).” Journal of the American Academy of Dermatology 2018 November 79|5|Pages 869-877

Baumann, L., Shridharani, S.M., Humphrey, S., Gallagher, C.J., “Personal (Self) Perceptions of Submental Fat Among Adults in the United States.” Dermatologic Surgery 2018 Sep 17. doi: 10.1097/DSS.0000000000001648. [Epub ahead of print].

Baumann, L., et al. "465 A-101 (hydrogen peroxide) topical solution safety and efficacy in patients with seborrheic keratoses: Results from two identical randomized, double-blind, placebo-controlled, phase 3 studies." Journal of Investigative Dermatology 138.5 (2018): S79.

Baumann L., Goldberg David J., Stein Gold, L., Tanghetti Emil A., Lain, E., Kaufman, J., Weng, E., Berk, David R., Ahluwalia, G., “Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial” Journal of Drugs in Dermatology 2018 March: 17:3 290-298

Draelos, Zoe Diana, et al. "Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial." Journal of the American Academy of Dermatology (2018).

Gold Michael H., Baumann L., Clifford Clark P. III., Schlessinger J., “A Multicenter, Double-Blinded, Ramdomized, Split-Face Study of the Safety and Efficacy of a Novel Hyaluronic Acid Gel for the Correction of Nasolabial Folds” Journal of Drugs in Dermatology 2018 January: 17:1 66-72

Baumann L., “Cosmeceuticals in Skin of Color” Seminars in Cutaneous Medicine and Surgery 2016 December: 35:4 233-237

Baumann LS., Zelickson B., “Evaluation of Micro-Focused Ultrasound for Lifting and Tightening Neck Laxity” Journal of Drugs in Dermatology 2016 May:15:5 611-618

Baumann LS., “Validation of a Questionnaire to Diagnose the Baumann Skin Type in All Ethnicities and in Various Geographic Location” Journal of Cosmetics, Dermatological Sciences and Application 2016 Mar:6:34-40

Baumann LS, Dayan S, Connolly S, Silverberg N, Xiaofang L, Drinkwater A, Gallagher CJ. “ Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow’s Feet Lines: Results from

Page ! of !7 50


Baumann L, Brandt F, Kane M, Donofrio L. “An Analysis of Efficacy Data from Four Phase III Studies of Botulinum Neurotoxin Type A-ABO for the Treatment of Glabellar Lines,” Aesthetic Surgery Journal. 2009:29(65):557-65.

Baumann L, Grunebaum LD, Bogdan Allemann I, Dayan S, Mandy S. “The risk of alar necrosis associated with dermal filler injection,” Dermatol Surg. 2009;35 Suppl 2:1635-40.

Baumann L, Woolery-Lloyd H, Friedman A. “’Natural’ ingredients in cosmetic dermatology,” J Drugs Dermatol. 2009:8(6Suppl):s5-9.

Baumann L, Allemann IB. “Antioxidantes,” Revista Chilena de Dermatologia. 2009; 25 (1): 8-20.

Allemann IB, Baumann L. “Botanicals in skin care products,” Int J Dermatol. 2009:48(9):923-34.

Castenedo MP, Baumann L. “Ethics of selling skin care,” Clin Dermatol. 2009:27(4):355-8. Brandt F, Baumann L, Huber B, Swanson N. “Randomized, Placebo-Controlled Study of a

New Botulinum Toxin Type A for Treatment of Glabellar Lines: Efficacy and Safety,” Dermatologic Surgery. 2009: 35:1-9.

Elsaie ML, Baumann LS, Elsaaiee LT. “Striae dinstensae (stretch marks) and different modalities of therapy: an update,” Dermatol Surg. 2009:35(4):563-73.

Ditre C, Wu J, Baumann LS, Rigel D. “Innovations in natural antioxidants and their role in dermatology,” Cutis. 2008:82(6 Suppl):2-16.

Baumann LS, Eichenfield LF, Nighland M, Rossi AB, Cook-Bolden F, Grimes P, Fried R. “Phase 4 study to assess tretinoin pump for the treatment of facial acne,” J Drugs Dermatol. 2008:7(12):1129-36.

Baumann LS, Pinsky MA, Thomas JA, Murphy DK, Walker PS. “Juvéderm injectable gel: a multicenter, double-blind, randomized study of safety and effectiveness,” Aesthet Surg. 2008:28(1):17-23.

Baumann LS. “Active naturals: ancient medicine enters the scientific age,” Semin Cutan Med Surg. 2008:27(3 Supple):5-7.

Allemann IB, Baumann L. Hyaluronic acid gel (Juvéderm™) preparations in the treatment of facial wrinkles and folds. Clin Interv Aging. 2008;3(4):629–634.

Bogdan Allemann I, Baumann L. "Botanical cosmeceuticals," Household and Personal Care Today 2008 (3):44

Bodgan Allemann I, Baumann L. “Hyaluronic acid gel (Juvéderm™) preparations in the treatment of facial wrinkles and folds,” Clinical Interventions in Aging 2008:3(4) 1-6.

Bogdan Allemann I, Baumann L. “Antioxidants Used In Skin Care Formulations,” Skin Therapy Letter 2008;13(7):5-9.

Baumann L. “Understanding and treating various skin types: the Baumann Skin Type Indicator,” Dermatol Clin. 2008:26(3):359-73.

Elsaie ML, Baumann LS. “Evaluation of liposomal delivery system for topical anesthesia,” Cutis. 2008:81(3):285-9.

Page ! of !8 50


Baumann LS, Shamban AT, Lupo M, Monheit GD, Thomas JA, Murphy DK, Walker PS, for the Juvéderm™ vs. Zyplast® Nasolabial Fold Study Group. “Comparison of Smooth-Gel Hyaluronic Acid Dermal Fillers with Cross-Linked Bovine Collagen: A Multicenter, Double-Masked, Randomized, Within-Subject Study,” Dermatologic Surgery 2007 Dec;33(S2):S128-S135.

Baumann L. “Botanical ingredients in cosmeceuticals,” Journal of Drugs in Dermatology 2007 Nov;6(11):1084-1088.

Baumann LS. “Less-known botanical cosmeceuticals,” Dermatologic Therapy 2007 Sep-Oct;20(5):330-342.

Baumann LS, Romanelli P, Marangoni O, Martin LK. “Keratoacanthomas as a Complication of Dermal Filler Injections,” Cosmetic Dermatology 2007 Jul;20(7):450-452.

Baumann L. “Melasma and Its Newest Therapies,” Cosmetic Dermatology 2007 Jun;20(6):349-353.

Baumann L, Narins R, Werschler, WP. “PART 2: Dermal Filling Agents: Evaluating More Choices for Your Patients,” Skin & Aging 2007 Jun;15(6):50-54.

Baumann L, Weinkle S. “Improving elasticity: The science of aging skin,” Cosmetic Dermatology 2007 Mar;20(3):168-172.

Baumann L. “PART 1: Dermal Filling Agents: Making the Right Choice for Your Patient,” Skin & Aging 2007 Mar;15(3):38-45.

Baumann L. “Skin ageing and its treatment,” Journal of Pathology 2007 Jan;211(2):241-251.

Baumann L, Rodriguez D, Taylor SC, Wu J. “Natural considerations for skin of color,” Cutis 2006 Dec;78(6 Suppl):2-19.

Baumann L. “Collagen-containing fillers: Alone and in combination,” Clinics in Plastic Surgery 2006 Oct;33(4):587-596.

Monteiro E, Baumann LS. “The science of cosmeceuticals,” Expert Review of Dermatology 2006 Jun;1(3):379-389.

Baumann L. “A new categorizing scheme for skin types,” Giornale Italiano de Dermatologia e Venereologia 2006 Jun;141(3):131-137.

Baumann L, Kaufman J, Saghari S. “Collagen fillers,” Dermatologic Therapy 2006 May;19(3):134-140.

Monteiro E, Baumann L, Welsh E, Kaufman J. “Cosmetic Dermatology: Beyond the Beauty,” Cosmetic Dermatology 2006 Apr;19(4):287-289.

Alam M, DesJardin J, Arndt KA, Dover JS, Hodapp RM, Baumann L, et al. “A quality rating scale for aesthetic surgical procedures,” Journal of the American Academy of Dermatology 2006 Feb;54(2):272-281.

Baumann LS. “Cosmetic Dermatology: Skin Type Categories,” Cosmetic Dermatology 2006 Feb;19(2):126-128,130.

Page ! of !9 50


Baumann L. “New Skin Typing System,” Skin and Aging 2006 Feb;14(2):60-64.

Baumann L, Amini S, Weiss E. “Nueva clasificación de los tipos de piel y sus implicaciones en Dermatología Cosmética,” Dermatología Venezolana 2005;43(4):4-7.

Baumann LS, Mauro AC. “Sunscreen use in the treatment of melasma,” Cosmetic Dermatology 2005 Nov;18(11):785-788.

Baumann L. “How to Prevent Photoaging?,” Journal of Investigative Dermatology 2005 Oct;125(4):xii-xiii.

Baumann L et al. “A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination cream in melasma patients previously treated with triple combination cream or one of its dyads,” Journal of Drugs and Dermatology 2005 Sep-Oct;4(5):592-597.

Baumann, L. “A dermatologist's opinion on hormone therapy and skin aging,” Fertility and Sterility 2005 Aug;84(2):289-290.

Baumann L, Vujevich J, Halem M, Martin LK, Kerdel F, Lazarus M, Pacheco H, Black L, Bryde J. “Open-Label Pilot Study of the Use of Alitretinoin 0.1% Gel (Panretin®) for the Treatment of Photoaging,” Cutis 2005 Jul;76:69-73.

Baumann L. “Using the 940-nm Laser for Facial Indications,” Cosmetic Dermatology 2005 Jun;18(6):407-410.

Baumann L, Monteiro E. “Can One Filler Do It All?,” Skin and Aging 2005 Jun;13(6):48-51.

Baumann L, Slezinger A, Halem M, Vujevich J, Martin LK, Black L, Bryde J. “A Pilot Study of the Safety and Efficacy of Myobloc™ (Botulinum Toxin Type B) for the Treatment of Axillary Hyperhidrosis,” International Journal of Dermatology 2005 May;44(5):418-424.

Baumann L, Slezinger A, Halem M, Vujevich J, Mallin K, Charles C, Martin LK, Black L, Bryde J. “Double-Blind, Randomized, Placebo-Controlled Pilot Study of the Safety and Efficacy of Myobloc (Botulinum Toxin Type B) for the Treatment of Palmar Hyperhidrosis,” Dermatologic Surgery 2005 Mar;31(3):263-270.

Baumann LS. “Safety Considerations for Retinol Use in Cosmetic Products,” Cosmetic Dermatology 2005 Jan;18(1 S1):9-13.

Bergfeld WF, Fowler JF, Baumann LS, Taylor SC. “The Four Seasons of Skin Care: The Utility of Natural Ingredients,” Cosmetic Dermatology 2004 Dec;17(12 S4):1-9.

Baumann L. “Dermal Fillers,” Journal of Cosmetic Dermatology 2004 Dec;3:249-250.

Baumann L. “Replacing Dermal Constituents Lost Through Aging with Dermal Fillers,” Seminars in Cutaneous Medicine and Surgery 2004 Sep;23(3):160-166.

Baumann L, Martin LK. “Myobloc for Facial Wrinkles,” Operative Techniques in Otolaryngology Head and Neck Surgery 2004 Jun;15(2):143-146.

Baumann L. “CosmoDerm/CosmoPlast (Human Bioengineered Collagen) for the Aging Face,” Facial Plastic Surgery 2004 May;20(2):125-128.

Page ! of !10 50


Baumann L. Halem M. “Botulinum Toxin-B and the Management of Hyperhidrosis,” Clinics in Dermatology 2004 Jan-Feb;22(1):60-65.

Baumann L. “Hyaluronic Acid in Fillers and Creams,” Skin and Aging 2004 Jan;12(12):86-88.

Baumann L, Frankel S, Welsh E, Halem M. “Cryoanalgesia with dichlorotetrafluoroethane lessens the pain of botulinum toxin injections for the treatment of palmar hyperhidrosis,” Dermatologic Surgery 2003 Oct;29(10):1057-1059.

Taylor SC, Torok H, Jones T, Lowe N, Rich P, Tschen E, Menter A, Baumann L, Wieder JJ, Jarratt MM, Pariser D, Martin D, Weiss J, Shavin J, Ramirez N. “Efficacy and Safety of a New Triple-Combination Agent for the Treatment of Facial Melasma,” Cutis 2003 Jul;72(1):67-72.

Baumann L, Halem M. “Soft Tissue Augmentation with Human Bioengineered Collagen,” Cosmetic Dermatology 2003 Jun;16(6):39-42.

Baumann L, Slezinger A, Vujevich J, Halem M, Bryde J, Black L, Duncan R. “A Double-Blinded, Randomized, Placebo-Controlled Pilot Study of the Safety and Efficacy of Myobloc (Botulinum Toxin Type B) Purified Neurotoxin Complex for the Treatment of Crow’s Feet: A Double-Blinded, Placebo-Controlled Trial,” Dermatologic Surgery 2003 May;29(5):508-515.

Baumann L, Black L. “Botulinum Toxin Type B (Myobloc),” Dermatologic Surgery 2003 May;29(5):496-500.

Baumann LS, Halem M. “Lip silicone granulomatous foreign body reaction treated with Aldara (imiquimod 5%),” Dermatologic Surgery 2003 Apr;29(4):429-432.

Baumann L. “Cosmetic definitions,” Journal of Cosmetic Dermatology 2003 Apr;2(2):100.

Baumann L, Halem M. “Systemic Adverse Effects after Botulinum Toxin Type B (Myobloc) Injections for the Treatment of Palmar Hyperhidrosis,” Archives of Dermatology 2003 Feb;139(2):226-227.

Shah NS, Lazarus MC, Bugdodel R, Hsia SL, He J, Duncan R, Baumann L. “The Effects of Topical Vitamin K on Bruising After Laser Treatment,” Journal of the American Academy of Dermatology 2002 Aug;47(2):241-244.

Alonso D, Lazarus MC, Baumann L. “Effects of Topical Arnica Gel on Post-Laser Treatment Bruises,” Dermatologic Surgery 2002 Aug;28(8):686-688.

Lazarus MC, Baumann L. “The Use of Cosmeceutical Moisturizers,” Dermatologic Therapy 2001;14:200-207.

Baumann L, Miyar ME. “Survey Examining Patients’ Perceptions of Cosmetic Products and Companies,” Cosmetic Dermatology 2001 Sep:19-20.

Baumann L, Romanelli P, Rigoni C. “Martiali iniettabili a confronto,” www.pelle.com 2001 March (In Italian).

Page ! of !11 50

http://www.pelle.com


Baumann LS, Kerdel FA, Agrawal A, Kirsner RS. “South Florida Survey on the Relationship Between Academic Medical Centers and Community Physicians,” Southern Medical Journal 1999 Jul;92(7):673-676.

Baumann LS, Spencer J. “The effects of topical vitamin E on the cosmetic appearance of scars,” Dermatologic Surgery 1999 Apr;25(4):311-315.

Baumann LS, Kerdel F. “The Treatment of Bovine Collagen Allergy with Cyclosporin,” Dermatologic Surgery 1999 Mar;25(3):247-249.

Baumann LS, Kelso EB. “Selections from current literature: androgenetic alopecia: the science behind a new oral treatment,” Family Practice 1998 Oct;15(5):493-496.

Columns

Bogdan Allemann I, Baumann L. News aus Miami: Eine neue Einteilung der Hauttypen (Teil 1). Dermatologie Praxis 2008(1):26.

Bogdan Allemann I, Baumann L. News aus Miami: Die Hauttypen –trocken versus ölig. Dermatologie Praxis 2008(2):26.

Bogdan Allemann I, Baumann L. News aus Miami: Hyperpigmentierungen richtig behandeln. Dermatologie Praxis 2008(2):20.

Bogdan Allemann I, Baumann L. News aus Miami: Auch im Alter faltenfrei? Dermatologie Praxis 2008(3):20.

Biweekly column in The Miami Herald, June 2007 – present.

Page ! of !12 50


Twice weekly Yahoo blog “Skin Guru” (www.skinguru.com), May 2007 – 2009.

Bimonthly column in AAPR Magazine, March 2008 - 2009.

Monthly column in Professional Beauty (Australia), November 2007 – present.

Monthly column “Cosmeceutical Critique” column in Dermatology News (Archives can be found at www.mdedge.com/dermatology), 2001 – present.

“Mercury,” August 2010.

“The Juicy Benefits of Acai Berry,” July 2010.

“Oleuropein,” June 2010.

“Phloretin,” April 2010.

“Senna Alata,” March 2010.

“Electric Stimulation,” February 2010..

“Sirtuins,” February 2010.

“Polyphenols,” January 2010.

“Organics,” December 2009.

“Carotenoids,” November 2009.

“Glucosamine,” October 2009.

“Luteolin,” September 2009.

“Dead Sea Minerals,” August 2009.

“Saffron,” July 2009.

“Rosmarinic Acid,” June 2009.

“Zeaxanthin,” May 2009.

“Polyphenols,” April 2009.

“β-Glucans,” March 2009.

“Cellulite,” February 2009.

Page ! of !13 50


“Cleansers,” January 2009.

“Barrier Repair Products,” December 2008.

“Stretch Marks,” November 2008.

“Argan Oil,” October 2008.

“Angelica: Part II,” September 2008.

“Angelica: Part I,” August 2008.

“Gold,” July 2008.

“Triterpenoids,” June 2008.

“Mahonia,” May 2008.

“Boldine,” April 2008.

“Apigenin,” March 2008.

“Bromelain (Pineapple Extract),” February 2008.

“Oils and Mineral Oil,” January 2008.

“Garlic,” December 2007.

“Caffeic Acid,” November 2007.

“Parabens,” October 2007.

“Mushrooms, Part III: Kombucha,” September 2007.

“Mushrooms: Part II,” August 2007.

“Prostaglandin Analogues,” July 2007.

“Mushrooms: Part I,” June 2007.

“Coffea Arabica and CoffeeBerry Extract,” May 2007.

“Licorice, Part II,” April 2007.

“Licorice, Part I,” March 2007.

“Hydroquinone,” February 2007.

“Organic Skin Care,” January 2007.

“Centella Asiatica (Gotu Kola),” December 2006.

“Boswellia,” November 2006.

Page ! of !14 50


“Ginseng,” October 2006.

“Glycerol,” September 2006.

“N-Acetylcysteine,” August 2006.

“Persimmon,” July 2006.

“Resveratrol,” June 2006.

“Rosemary,” May 2006.

“Echinacea,” April 2006.

“The 16 Skin Types,” March 2006.

“Polypodium Leucotomos,” February 2006.

“Horse Chestnut,” January 2006.

“Idebenone,” December 2005.

“Genistein,” November 2005.

“Ferulic Acid,” October 2005.

“Xylitol,” September 2005.

“Onion extract,” August 2005.

“Propolis,” July 2005.

“Sunflower Oil,” June 2005.

“Turmeric and Curcumin,” May 2005.

“Red Clover,” April 2005.

“Cocoa and Chocolate,” March 2005.

“Your Own Line: Does Business Trump Science?,” February 2005.

“Quercetin,” January 2005.

“Silymarin,” December 2004.

“Oatmeal,” November 2004.

“Pycnogenol,” October 2004.

“Caffeine,” September 2004.

“Olive Oil,” August 2004.

Page ! of !15 50


“St. John’s Wort,” June 2004.

“A Refresher on Antioxidants,” May 2004.

“Prevention and Treatment of Sun Damage: Preserving Cosmetic Integrity,” Supplement.

“Dexpanthenol,” April 2004.

“Evening Primrose Oil,” March 2004.

“Lutein,” February 2004.

“Pomegranate,” January 2004.

“Hyaluronic Acid,” December 2003.

“Grape Seed Extract,” November 2003.

“Calendula,” October 2003.

“Lavender,” September 2003.

“Ginger,” August 2003.

“Chamomile,” July 2003.

“Topical Treatments for Photodamage,” “Cosmeceuticals: A New Category of Skin Care Agents,” July 2003 Supplement.

“Allantoin,” June 2003.

“Zinc,” May 2003.

“Aloe Vera,” April 2003.

“Topical Estrogen,” March 2003.

“Melasma and the Challenges of Treating Skin of Color,” February 2003 Supplement.

“Phosphatidylcholine,” February 2003.

“Skin Care Suggestions for Patients,” January 2003.

“Lycopene,” December 2002.

“Tea Tree Oil,” November 2002.

“International Dermatologic Education,” October 2002.

“Selenium,” October 2002.

Page ! of !16 50


“Biotin,” September 2002.

“Niacinamide,” August 2002.

“Fragrance,” July 2002.

“DMAE,” June 2002.

“Testing,” May 2002.

“Vitamin K,” April 2002.

“Claims,” March 2002.

“Stability,” February 2002.

“Co-Enzyme Q10,” January 2002.

“DHEA,” December 2001.

“Copper,” November 2001.

“Kinetin,” October 2001.

“Salicylic Acid,” September 2001.

“Soy and its Isoflavones,” August 2001.

“Vitamin E,” July 2001.

“Alpha-Hydroxy Acid,” June 2001.

“Vitamin A, Retinol, and Retinoids,” May 2001.

”Lipoic Acid,” April 2001.

“Arnica Montana L,” March 2001.

“Green Tea,” February 2001.

“Vitamin C,” January 2001.

Monthly Column

“Cosmetic Dermatology Topics” column in Skin and Aging, January 1999 – October 1999.

Machado C, Baumann L. “The Cosmetic Uses of Botulinum Toxin,” 1999 Oct;7(10):79- 80.

Bogensberger G, Baumann L. “What You Should Know About Sensitive Skin,” 1999 Sep;7(9):75-78.

Page ! of !17 50


PROFESSIONAL

Research—Industry Funded

Oct 2018 – present Clinical Trial to Evaluate ET-01 in Subjects with Lateral Canthal Lines (Study 2)

Oct 2018 – present A Phase 2A, Open Label Study Evaluating the Safety and Different Injection Techniques of CCH for the treatment of Edematous Fibrosclerotic Panniculopathy

Oct 2018 – present A Randomized, Evaluator-Blinded, Parallel, Comparator-Controlled Study to Evaluate the Safety and Effectiveness of GAL1704 for Cheek Augmentation and correction of Midface Contour Deficiencies

Sep 2018 – present A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects with Alopecia Areata, Alopecia Universalis or Alopecia Totalis

Sep 2018 – present A Multicenter, Randomized, Open-label, Phase 3 Long-term Safety Study of Topically Applied Sofpironium Bromide (BBI-4000) Gel, 5% and 15% in Subjects with Axillary Hyperhidrosis

Yang D, Baumann L. “How to Treat Post-inflammatory Hyperpigmentation,” 1999 Aug;5:81-85.

Baumann L. “Understanding the Scientific Basis of Sound Hair Care,” 1999 Jul;7:89-91.

Imamnuaysup S, Baumann L. “Oral Supplements for the Skin,” 1999 Jun;7(5):63-65.

Keri J, Baumann L. “The Science behind Vitamin C,” 1999 May;7(4):79-80.

Bogensberger G, Baumann L. “How to Choose the Best Sunscreen for Your Patient,” 1999 Apr;7(3):79-81.

Hary C, Baumann L. “A Comparison of Today’s Treatment Options for Soft Tissue Augmentation,” 1999 Mar;7(3):88-94.

Hary C, Baumann L. “How Do Bovine and Porcine Collagen Compare?,” 1999 Feb;7(2): 71-72.

Baumann L, Abuchar A. “Understanding the Chemistry and Application of Salicylic Acid,” 1999 Jan;7(1):85-88.

Page ! of !18 50


Sep 2018 – present A Phase 3 Randomized Withdrawal, Double-Blind, Placebo-Controlled, Multi-Center Study investigating the Efficacy and Safety of PF-04965842 in subjects aged 12 years and over, with moderate to severe Atopic Dermatitis with the option of rescue treatment in flaring subjects.

Aug 2018 – present A Randomized, Double-Blind, Placebo-Controlled, Efficacy Study of the Neurokinin-1 Receptor Antagonist VLY-686 in patients with Atopic Dermatitis.

Aug 2018 – present A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S5G4T-1 in the Treatment of Papulopustular Rosacea

Jul 2018 – present A Phase 1, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of AGN-151607 After Single Intramuscular Treatment in Subjects with Glabellar Lines

Aug 2018 – present Clinical Trial to Evaluate ET-01 in Subjects with Lateral Canthal Lines (Study 1)

Jun 2018 – present Open-Label, Long-Term Study to Evaluate the Safety and Temporal pattern of response of EN3835 in the treatment of Edematous Fibrosclerotic Panniculopathy

May 2018 – present A Phase 4, Multicenter, Open-Label Safety Study of Crisabole Ointment 2% in Children Aged 3 Months to Less Than 24 Months with Mild to Moderate Atopic Dermatitis.

Apr 2018 – present A Phase 3, Randomized, Double-Blind, Placebo-Controlled study of EN3835 in the treatment of Edematous Fibrosclerotic Panniculopathy

Mar 2018 – Sep 2018 A multicenter, single-blind, randomized, controlled study of the safety and effectiveness of JUVÉDERM VOLUMA® XC injectable gel for cheek augmentation using cannula

Jul 2017 – Nov 2017 A Randomized, Double Blinded, Vehicle-Controlled, Parallel Group Study of Safety and Effectiveness of (Study Drug) Topical Solution Applied Once A Week in Subjects With Common Warts.

Apr 2017 – Apr 2018 A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Safety and Effectiveness of (Study Drug) 40% and 45% Topical Solution in Subjects with Seborrheic Keratosis Lesions on the Trunk, Extremities and Face

Mar 2017 –Aug 2018 A Phase 3, Randomized, Double Blind, Vehicle-Controlled, Multi-

Page ! of !19 50


Center Study to Evaluate the Efficacy and Safety of (Study Drug) versus Vehicle in Subjects 2-11 years of age with Cutaneous Common Warts.

Jan 2017 – Sep 2017 A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of a Once-Daily XXX Topical Versus Vehicle Administered for 12 Weeks to Subjects with Papulopustular Rosacea with a 4 Week Follow-up Period

Jul 2016 – present A multicenter, single-blind, randomized, controlled study of the safety and effectiveness of XXX injectable gel for chin augmentation

Jul 2016 – Feb 2017 Clinical Study to Evaluate the Safety and Efficacy of the XXX Power Device Using the XXX Power Transducer for Abdominal Fat and Circumference Reduction

Mar 2016- Jan 2017 A Randomized, Double-Blin, Vehicle-Controlled, Parallel Group Study of the Safety and Effectiveness of XXX Solution 40% in Subjects with Seborrheic Keratosis on the Trunk, Extremities and Face (Study 2)

Aug 2015- Feb 2017 A Multicenter, Open Label, Multiple dose Phase II trial to

Demonstrate the Safety of XXX in Adult Subjects for Treatment of Moderate to Severe Glabellar lines

Aug 2015- Jun 2017 Open label, single blinded, randomized study, evaluating the

efficacy and safety, of XXX for the facial temporal regions Aug 2015 – Jan 2016 A Double-Blind Extension Study to Evaluate the Post-Treatment

Safety and Duration of Clinical Effect of XXX in Subjects Who Completed Either the XXX or XXX Study

Jun 2015 – Nov 2016 A Multi-Center, Randomized, Double-Blinded, Split Face Study to

Evaluate the Safety and Efficacy of XXX vs Restylane for the Correction of Nasal Labial Folds

May 2015- present A Prospective, Open-Label, Multicenter Study to Evaluate the Long-Term Safety of XXX in Immuno-Competent Subjects Stratified by Fitzpatrick Skin Type I-VI

Page ! of !20 50


Apr 2015 - Dec 2015 A Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Effectiveness and Safety of XXX for the Reduction of Central Abdominal Bulging due to Subcutaneous Fat in Non-Obese Subjects

Sep 2015 – Feb 2016 Clinical Trial To Evaluate XXX in the Treatment of Primary

Axillary Hyperhidrosis in Adults Dec 2014- Dec 2015 A Multi-Center, Prospective, Randomized, Single-Blind, Within-

Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of XXX on the Outcome of Keloid Excision Surgery in Healthy Adults

Oct 2014- Jul 2016 Evaluation of the Safety and Efficacy of Treatment with XXX

(Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects with Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)

May 2014- Sep 2015 A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of XXX Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

May 2014- Jul 2015 Efficacy and Safety of XXX HCI Cream 1.0% for the Treatment of Persistent Erythema Associated with Rosacea

Mar 2014- May 2015 A Safety and Efficacy Study to Compare Dermal Gel with Vehicle Control in Patients with Acne Vulgaris

Apr 2014- Oct 2015 A Long-term Safety and Efficacy Study of XXX HCI Cream 1.0% in Patients with Persistant Erythema Associated with Rosacea

Apr 2014- Dec 2014 Single Centered, Single-Blinded, Randomized Comparison Study of Two Antibacterial Skin Cleansing Cloths to Determine Differences in Skin Hydration and Tolerability

Sep 2013- Jan 2014 A Multi-Center Clinical Trial to Evaluate the Safety and Efficacy of

Two Acne Regimens in Individuals with Mildly Moderate to Moderate Acne Vulgaris

Sep 2013-Jan 2014 Dose Finding Study of BoNT/A in Subjects with Crow’s Feet (Lateral Canthal Lines)

Page ! of !21 50


Jan 2013-Jun 2014 Randomized, Double-Blind, Placebo Controlled Trial Assessing The Effects of An Oral Dietary Supplement Containing Marine And Plants Extracts On Overall Facial Skin Appearance Among Healthy Adult Women With Photo-Aged Skin

Mar 2013- Jul 2013 Clinical Trial to Evaluate ANT-1401 in Subjects with Lateral

Canthal Lines

Mar 2013- Jul 2013 Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis in Adults

Feb 2013- Jun 2013 A Multi-center, Randomized, Double-Masked, Placebo-Controlled, Multi- Factorial Evaluation of the Safety and Efficacy of Fluticasone Propionate (FP) and Salmeterol Xinafoate (SX) Compared with Placebo or Salmeterol Xinafoate Alone or Fluticasone Propionate Alone for the Reduction of Abdominal Adiposity

Jan 2013-Aug 2013 Safety and Efficacy of Oxymetazoline HCl Cream For the Treatment of Erythema Associated with Rosacea

Apr 2012- Jul 2013 A Randomized, Evaluator- Blinded, No-Treatment-Controlled Study of the Effectiveness and Safety of Small Particle Hyaluronic Acid plus Lidocaine (SPHAL) in the Augmentation of Soft Tissue Fullness of the Lips

Mar 2012-Apr 2013 Evaluation of a beauty FAN Device

Mar 2012- Oct 2013 Multicenter, Randomized, Double-Blind, Placebo-controlled, Phase 3 study of ATX-101(sodium deoxycholate injection) versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Mar 2012- Jul 2014 A Phase 3 Randomized Placebo-Controlled Study of the Use of Artefill for Moderate to Severe Atrophic Acne Scar Correction

Feb 2012- Aug 2012 A Multi- Center, Double-Blind, Randomized, Vehicle-Controlled, Dose-Range Study of Encapsulated Benzoyl Peroxide Gel, 1% and 5%, and Vehicle Gel in the Treatment of Rosacea

May 2011- May 2012 A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study to Demonstrate the Efficacy and Assess the Safety of CD07805/47 gel 0.5% Applied Topically Once Daily in

Page ! of !22 50


Subjects with Moderate to Severe Facial Erythema associated with Rosacea.

Apr 2011-Apr 2012 Clinical Trial to Evaluate (ANT-1207) In Subjects with Lateral Canthal Lines

Apr 2011-Sep 2011 Clinical Trial to Evaluate Botulinum Neurotoxin Type A (ANT-1207-101-ACNE) In Subjects With Acne

Mar 2011- Jan 2012

Feb 2011– Jan 2012

Oct 2010 –Oct 2011

Sep 2010 –May 2012

Clinical Trial To Evaluate Sweat Production in Subjects With Primary Axillary Hyperhidrosis in Adults

Evaluation of the Ulthera® System for Lifting and Tightening the Face and Neck

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Single Treatment Cycle Study of BOTOX® Purified Neurotoxin Complex in Subjects with Lateral Canthal Rhytides

A Pivotal USA Randomized, Evaluator-Blinded, Active-Controlled, Multi-Center, Split-Face Comparison Study of Emervel Deep Lidocaine Versus Juvederm® Ultra Plus in the Treatment of Moderate to Severe Facial Wrinkles and Folds

Aug 2010 – Jun 2011 A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of the Dose-Response Profile of V-101 Cream in Subjects with Erythematous Rosacea

Jun 2010 – Oct 2010 An Evaluation of the Safety and Effectiveness of the BEAM Device in the Treatment of Mild-to-Moderate Acne

May 2010 – Jan 2013 A Multicenter, Double-Masked, Randomized, Parallel-Group Study Assessing the Safety and Efficacy of Once Daily Application of Bimatroprost Solution 0.03% Compared to Vehicle to Treat Chemotherapy Induced Eyelash Hypotrichosis in Pediatric Subjects

Page ! of !23 50


Mar 2010 – Aug 2011 A One Year Multicenter Double-Masked Randomized Parallel-Group Study Assessing the Safety and Efficacy of Once Daily Application of Bimatoprost 0.03% Solution Compared to Vehicle to Treat Hypotrichosis of the Eyelashes from Varied Etiologies

Nov 2009 – Aug 2014 A Multicenter Single-Blind Randomized “No-Treatment” Control Study of the Safety and Effectiveness of JUVÉDERM® VOLUMA XC Injectable Gel for Cheek Augmentation to Correct Age-Related Volume Deficit in the Mid Face

Oct 2009 – Jan 2011 A Multicenter Randomized Double-Blind Vehicle-Controlled Parallel-Group Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1% in Subjects with Acne Vulgaris

Jan 2009 – Sep 2009 A Phase 3, Multicenter, Randomized, Double-blind, active and vehicle-controlled study of the safety and efficacy of Duac low-dose gel versus Clindamycin gel versus Benzoyl Peroxide gel versus vehicle gel in subjects with acne vulgaris

Sep 2008- Jul 2009 An Open-label Topical Lidocaine Study to Further Assess Perceptions of Pain and Determine Lidocaine Blood Plasma Concentrations at Specific Randomized Time Points for Injections of Botox® Used for Crow’s Feet Wrinkles

Nov 2007 – Oct 2009 A Prospective, Randomized, Controlled Pilot Study of Apligraf(R) for the Treatment and Prevention of Recurrence of Excised Keloids

May 2007 – May 2008 A Subject- and Evaluator-Blinded, Randomized, Multi-Center Study to Evaluate the Safety and Effectiveness of Injection with DGE Injectable Gel as Compared to an FDA-Approved Dermal Filler in Subjects Undergoing Cutaneous Correction of Nasolabial Folds

Dec 2006 – Aug 2007 The P.U.M.P. Study: Patients Using MICRO Properly; An Open-label, Community Based, Phase Four Study to Assess Facial Acne Improvement with Use of RETIN-A MICRO® (Tretinoin Gel) Microsphere, 0.04% or 0.1% in a Pump Dispenser

Page ! of !24 50

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%255bOID%255b8E051BDD5C0D664FA2B23CB487A2BD82%255d%255d

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%255bOID%255b9B061DBD9A82D14A8F3A21716B2A2949%255d%255d

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%255bOID%255b7417B71C660A614393613DEBBE0074C5%255d%255d


Jul 2006 – Mar 2011 A Phase 3, Multicenter, Open-Label Extension Study to Assess the Long-Term Safety of Repeat Administrations of Reloxin® in the Treatment of Glabellar Lines

Oct 2005 – Feb 2007 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Reloxin™ in the Treatment of Glabellar Lines

Oct 2005 – Nov 2008 A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Study of the Safety and Efficacy of Two Sequential Treatments with BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Primary Palmar Hyperhidrosis Followed by Repeated Open Label Treatments with BOTOX®

Aug 2005 – Jun 2007 A Multicenter, Open-Label Study of the Safety and Efficacy of Repeated Treatments with BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Primary Axillary Hyperhidrosis in Adolescents

Apr 2005 – Oct 2006 A multi-center follow-up evaluation of efficacy and safety after repeat treatment with Juvéderm® Hyaluronate Gel Implants for the correction of Nasolabial Folds

Aug 2004 – Sep 2006 A Multi-Center, Randomized, Within-Patient Controlled Study to Evaluate the Safety and Efficacy of Juvéderm® Hyaluronate Gel Implants vs. Zyplast® Collagen Implant for the Correction of Nasolabial Folds

Jul 2004 – Mar 2007 A Randomized Study of the Safety and Effectiveness of DL6049 Injectable (Poly-L-Lactic Acid) versus CosmoPlast™ Human Based Collagen Implant in the Treatment of Nasolabial Fold Wrinkles

Page ! of !25 50


Jun 2004 – Mar 2005 A Phase III, Randomized, Double-Blinded, Placebo-Controlled Study to Assess the Efficacy and Safety of 52120 in the Treatment of Glabellar Lines

May 2004 – Mar 2005 Clinical Efficacy Studies of the Use of Topical Cosmetic Products in Orbital Skin Region

Feb 2004 – Mar 2005 The Controlling Lesions and Erythema with Azelaic Acid Gel Regimen (CLEAR) Study: A Multicenter Efficacy and Safety Study of Azelaic Acid (AzA) 15% Gel in Combination and Maintenance Therapy of Moderate Papulopustular Rosacea to Severe Papulopustular Rosacea: An Open-Label, 12-week study of Combined Topical AzA 15% Gel and Systemic Doxycycline Monohydrate followed by a Double-Blind, Randomized 24-week Comparison of AzA 15% Gel with its Vehicle in Maintaining Remissions of Rosacea

Oct 2003 – Aug 2004 A Multiple Center, Randomized, Evaluator Blind Study of the Safety and Efficacy of Fluocinolone Acetonide 0.01%, Hydroquinone 4%, Tretinoin 0.05% (Tri-Luma™) Cream Versus Its Three Paired Active Ingredients Creams in the Treatment of Post Inflammatory Hyperpigmentation

Jun 2003 – Mar 2005 An Open-Label, Split-Site, Pilot Study of the Use of Targretin® Gel for the Treatment of Seborrheic Keratoses, (SKs)

Jul 2002 – Jun 2004 Double Blinded, Randomized, Multi-Center Evaluation of the Safety and Efficacy of Hylaform Viscoelastic Gel as Compared to Zyplast Collagen Implant in Patients Undergoing Cutaneous Correction of Nasolabial Folds

Mar 2002 – Feb 2003 Double Blinded, Randomized, Placebo-Controlled Study of the Safety and Efficacy of MYOBLOC™ (Botulinum Toxin Type B) Purified Neurotoxin Complex for the Treatment of Palmar Hyperhidrosis

Page ! of !26 50


Mar 2002 – Jan 2003 A Pilot Study of the Use of Panretin® Gel (Alitretinoin Gel) for the Treatment of Photodamage

Mar 2002 – Mar 2006 Multicenter, Open-Label Study of the Safety of BOTOX® (botulinum toxin type A) Purified Neurotoxin Complex for the Treatment of Primary Axillary Hyperhidrosis

Nov 2001 – Sep 2002 Double Blinded, Randomized, Placebo-Controlled Study of the Safety and Efficacy of MYOBLOC™ (Botulinum Toxin Type B) Purified Neurotoxin Complex for the Treatment of Crow’s Feet

Nov 2001 – Nov 2002 Double Blinded, Randomized, Placebo-Controlled Study of the Safety and Efficacy of MYOBLOC™ (Botulinum Toxin Type B) Purified Neurotoxin Complex for the Treatment of Axillary Hyperhidrosis

Feb 2001 – Oct 2002 Multicenter, Double Blind, Randomized, Placebo Controlled Parallel Study of the Safety and Efficacy of Repeated Treatment with One or Two dosages of BOTOX® (botulinum toxin type A) Purified Neurotoxin Complex for the Treatment of Primary Axillary Hyperhidrosis

Nov 2000 – Apr 2002 Efficacy and Safety of TRADENAME (0.01% Fluocinolone acetonide + 4% Hydroquinone + 0.05% Tretinoin) in the Treatment of Patients with Cutaneous Melanosis of the Face (melasma)

Aug 2000 – Nov 2000 Efficacy and Safety of TRADENAME (0.01% Fluocinolone acetonide + 4% Hydroquinone + 0.05% Tretinoin) in the Treatment of Patients with Cutaneous Melanosis of the Face (melasma)

Sep 2000 – Jan 2001 Effects of topically applied Clinac™ on the efficacy of sunscreen in a bovine model

Page ! of !27 50


Research—Self Funded

Jun 2010 – Mar 2011 A Single Center, Single Blind Study on the Efficacy of a Combination Regimen of Extraction and Retinoid verses Retinoid Only on Treating Facial Acne Vulgaris

Jul 2000 – Mar 2001 Randomized Inter-Rater and Intra-Rater Reliability Study of Gravimetric Measurement of Spontaneous Resting Axillary Sweat Production Both in Patients with and Without Primary Axillary Hyperhidrosis

Oct 1999 – Apr 2000 Open-label trial of Botox® for brow furrow wrinkles

Jun 1999 – Oct 1999 Double-blind trial examining the cosmetic use of Botox® for brow furrow wrinkles

1996 – 1997 Double blinded placebo controlled trial comparing the effects of Dermasmooth-FS™ versus placebo in Atopic Patients

Apr 2010 – Feb 2011 A Single Center Randomized Single-Blind Trial Comparing the Facial Skin Appearance of Subjects Actively Participating in Yoga with Subjects Leading Sedentary Lifestyles

Jan 2009 – Oct 2009 Skin Repository for Skin Types Classified According to the Baumann Skin Type Indicator (BSTI)

Nov 2008- Oct 2009 Designating gene expression signatures for oily and dry skin types - Phase II

Page ! of !28 50

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%255bOID%255bBF445D3D18A03140BDBE401DEB802525%255d%255d

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%255bOID%255b6ECF16B47C63CA49AD273E57A30CC15E%255d%255d


Oct 2008 – Oct 2009 A Randomized Double-Blind Placebo Controlled Study Evaluating the Effectiveness and Tolerability of Oral Polypodium Leucotomos in Patients with Melasma

Oct 2008 – Oct 2009 Single Center, Prospective Clinical Trial Using the Pearl® (Cutera) Laser System for Chest Sun Damaged Skin and Comparison of Resurfix versus Aquaphor Occlusive Dressings in Healing

Aug 2008 – Mar 2009 A Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of the Titan Infrared Device for Skin Tightening of the Aging Abdomen

Mar 2008 – Mar 2009 A Comparative Analysis of the Oily Versus Dry Scores That Are Derived from Using the Baumann Skin Type Scoring System (BSTI) and Sebum Levels Derived from Sebumeter® Measurements, Trans-epidermal Water Loss Measurements Derived from Tewameter® Measurements

Feb 2008- Feb 2009 A retrospective pilot study evaluating the effects of gender and pre-menopausal versus post-menopausal status (in women) on the efficacy of Sculptra® (injectable poly-L-lactic acid) in patients treated for facial rejuvenation

Aug 2003 – Sep 2006 A Double-Blinded, Randomized Study Evaluating the Efficacy and Safety of Claripel™ Cream for Treatment of Melasma and Post-Inflammatory Hyperpigmentation

Jul 2003 – Sep 2006 A Single-blinded, Placebo-controlled Clinical Trial Evaluating the S a f e t y a n d E f f i c a c y o f To p i c a l A n e s t h e s i a w i t h Dichlorotetrafluoroethane (Frigiderm™) Prior to Botulinum Toxin Type A (Botox®) Injections for Palmar Hyperhidrosis

Jul 2003 – Jul 2005 An Open-Label Pilot Study Evaluating the Safety and Efficacy of CosmoPlast™ Human-Bioengineered Collagen Implant in Patients Undergoing Cutaneous Correction of Nasolabial Folds

Page ! of !29 50

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%255bOID%255b6E043C5D4F2277498D6C64E3A9D0AFB6%255d%255d

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%255bOID%255b7114270BF1F1754781E7F94B3F9C17AC%255d%255d

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%255bOID%255b5DE57CDEA2D89D48861FFE9B690BCDB3%255d%255d

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%255bOID%255b3EF0A38BD81066418E051A2008FC12D3%255d%255d

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%255bOID%255b90A6EDCE1D441D44AB66FD7E22CA8335%255d%255d


Professional and Honorary Organizations

Jan 2002 – May 2003 The Effect of Using a 940nm Diode-Laser to Improve the Appearance of Scars with Erythema

August 2000 Double-blind placebo-controlled trial examining the effects of Arnica on bruising

May 2000 Double-blind placebo-controlled trial examining the effects of Vitamin K on Bruising

October 2000 Survey examining patient’s perceptions of the cosmetic companies

1996 – 1997 Double blind placebo controlled trial examining the effects of Vitamin E on the cosmetic appearance of scars

A Comparative Analysis of the Oily Versus Dry Scores That Are Derived from Using the Baumann Skin Type Scoring System (BSTI) and Sebum Levels Derived from Sebumeter® Measurements, Trans-epidermal Water Loss Measurements Derived from Tewameter® Measurements

Societies

American Dermatologic Association (ADA)

Women’s Dermatologic Society

American Academy of Dermatology (AAD)

American Society for Dermatologic Surgery (ASDS)

Society of Investigative Dermatology (SID)

Florida Society of Dermatology

Page ! of !30 50

https://eprost.med.miami.edu/Eprost/Rooms/DisplayPages/LayoutInitial?Container=com.webridge.entity.Entity%255bOID%255b7114270BF1F1754781E7F94B3F9C17AC%255d%255d


Other Professional Activities

Board Memberships

Committees

Editorial responsibilities

Associations

American Dermatology Association (ADA)

Association of Clinical Research Professionals (ACRP)

April 2000 – present Foundation for International Dermatologic Education (FIDE)

February 2004 – 2009 International Society of Dermatology Member, Board of Directors Chair, Industry Liaison Committee

American Society for Dermatologic Surgery Post Graduation Education Committee, December 2000 – March 2003 Membership Recruitment and Retention Committee, December 2000 – March 2002 Applicant Review Committee, December 2001 – 2007 Research Committee, December 2001 – 2007 Industry Liaison Committee, June 2003 – 2007 Sub-committee on Topical Therapeutics, October 2003 – 2007

American Academy of Dermatology Quality of Care Task Force, March 2002 – 2007

International Society of Dermatology Chair, Corporate Membership Committee, June 2003 – present Chair, Industry Liaison Committee, June 2003 – present

Page ! of !31 50


Miami Herald – Skin Deep Column – June 2007- present

Honors and Awards

Scientific Presentations

Aesthetician Presentations

Contributing Editor, Skin and Allergy News, and writer of monthly column titled “Cosmeceutical Critique”, December 2000 – present

Member, Editorial Board, Skin Cancer Foundation Journal, August 2004 – 2005

Member, Surgical Advisory Board, Archives of Dermatology, February 2002 – 2007

Member, Editorial Board, International Journal of Dermatology, March 2002 – 2005

Member, Editorial Board, Brazilian Journal of Dermatologic and Cosmetic Surgery – Surgical and Cosmetic Dermatology, February 2009 - 2005

2018

2018

2016

2014

February 2007

My Face My Body Award for Aesthetic Practice of the Year South

The Commonwealth Institute-South Florida for Top Women-Led Businesses in Florida

My Face My Body Award for Aesthetic Practice of the Year South

The Common Wealth Institute

AIA Florida Honor Award/Interior Design

Nomination for Books for a Better Life Award for The Skin Type Solution

Page ! of !32 50


Dermatology Presentations

November 2018 “Dermal Fillers” AAAM Congress, Miami, FL

October 2018 “The Business of Skin Care” ASDS Annual Meeting, Phoenix, AZ

June 2018 “10 Ways To differentiate Your Practice” Vegas Cosmetic Surgery Conference, Las Vegas, NV

June 2018 “Pre and Postoperative Skin Care” Vegas Cosmetic Surgery Conference, Las Vegas, NV

May 2018 “Cosmeceuticals for Aging Skin” Cincinnati Dermatological Society, Cincinnati, OH

May 2018 “Skincare Product Basic Science” Cincinnati Dermatological Society, Cincinnati, OH

May 2018 “Product Layering To Optimize Skincare Regimens” Cincinnati Dermatological Society, Cincinnati, OH

November 2017 “Cosmeceuticals and Formulations” AAAM Congress, Miami, FL

April 2010 “Skin Care by Skin Type,” International Congress of Esthetics and Spa, Miami Beach, FL.

November 2009 “Skin Care by Skin Type,” Miami-Dade Area Health Education Center (AHEC), Miami, FL.

January 2008 “Skin Care by Skin Type,” International Congress of Esthetics & Spa, Miami, FL.

February 2007 “Skin Care by Skin Type,” Society of Dermatology Skincare Specialists, Washington, DC

February 2007 “Skin Care for Sensitive Skin,” Dermatology Nurses Association, Washington, DC

Page ! of !33 50


June 2017 “Streamlining Staff Education” Vegas Cosmetic Surgery Conference, Las Vegas, NV

January 2017 “Long-term Safety and Efficacy of Oxymetazoline Cream 1.0% for Treatment of Persistent Facial Erythema Associated With Rosacea: Results From the 52-Week REVEAL Study.” VirginDerm 2017, St. Thomas, Virgin Islands

November 2016 “Personal and Social Impacts of Submental Fat in the US Population,” American Society for Dermatologic Surgery, New Orleans, LA

June 2016 “Skincare Retail the Easy and Scientific Way” Vegas Cosmetic Surgery 2016, Las Vegas, NV

September 2014 New Jersey Derm Dinner

April 2010“Skin Care by Skin Type,” Australasian College of Cosmetic Surgery Annual Conference, Adelaide, Australia. “International Interactive Forum on Face,” Australasian College of Cosmetic Surgery Annual Conference, Adelaide, Australia. “Approach to the Aging Face,” Australasian College of Cosmetic Surgery Annual Conference, Adelaide, Australia. “Dermal Fillers,” Australasian College of Cosmetic Surgery Annual Conference, Adelaide, Australia.

“Interactive Laser Panel,” Australasian College of Cosmetic Surgery Annual Conference, Adelaide, Australia.

March 2010 “Advanced Botulinum Toxin- Live Patient Demonstration,” American Academy of Dermatology Annual Meeting, Miami Beach, FL. “What’s Available and Where to Put It,” Soft Tissue Augmentation Course, American Academy of Dermatology Annual Meeting, Miami Beach, FL.

Page ! of !34 50


January 2010 “Anti-Aging Skin Care,” Dermatology Topics in the Tropics Cruise. “Choosing a Hyaluronic Acid Filler,” Dermatology Topics in the Tropics Cruise. “When Cosmetic Procedures Run Amok...What Can Go Wrong?” Dermatology Topics in the Tropics Cruise. “Botox for Beginners With a Nod to Experience,” Dermatology Topics in the Tropics Cruise. “Ethics of Selling Skin Care Products,” Dermatology Topics in the Tropics Cruise. “Challenging Cases in Medical Dermatology, Cosmetic Dermatology and Dermatopathology,” Faculty Panel, Dermatology Topics in the Tropics Cruise.

November 2009 “Cosmeceutical Concepts: The Way I Do It,” Skin Disease Education Foundation Las Vegas Dermatology Seminar, Las Vegas, NV. “The Science of "Active" Natural Ingredients in Skin Care Products,” Skin Disease Education Foundation Las Vegas Dermatology Seminar, Las Vegas, NV.

October 2009 “Novel Approaches to the Aging Face,” Fall Clinical Dermatology Conference, Las Vegas, NV.

May 2009 Chairman, Facial Rejuvenation Symposium, 10th International Congress of Dermatology, Prague, Czech Republic. “Comparing HA Fillers,” Facial Rejuvenation Symposium, 10th International Congress of Dermatology, Prague, Czech Republic. “The Truth About Cosmeceuticals,” Broad Based Overview of Cosmetic Procedures in Dermatology Course, 10th International Congress of Dermatology, Prague, Czech Republic.

March 2009 “Comparing HA Fillers,” Soft Tissue Augmentation Course, American Academy of Dermatology Annual Meeting, San Francisco, CA. “Skin Care for Sensitive Skin Types,” Roundtable Discussion, American Academy of Dermatology Annual Meeting, San Francisco, CA. “Skin Care for Sensitive Skin Types,” Symposium on Acne and Rosacea, American Academy of Dermatology Annual Meeting, San Francisco, CA.

January 2009 “Skin Care by Skin Type,” Orlando Dermatology Association Conference, Orlando, FL. “HA Fillers and Collagen Stimulators,” Orlando Dermatology Association Conference, Orlando, FL.

Page ! of !35 50


September 2008 “Integrating Quality Skin Care into Your Facial Plastic Surgery Practice,” American Academy of Facial Plastic and Reconstructive Surgery Meeting, Chicago, IL

July 2008 "Role of Natural Ingredients in Managing Inflammatory Skin Conditions," New Innovations in Antioxidants Symposium, American Academy of Dermatology Summer Meeting, Chicago, IL

June 2008 “Injectable Fillers and Neurotoxins - Essential to Your Practice? - Live Injection Session- Lips,” Facial Cosmetic Surgery Conference, Las Vegas, NV “Skin Care by Skin Type,” Facial Cosmetic Surgery Conference, Las Vegas, NV Panelist – “The Masters” Skin Clinic- Dilemmas and Case Studies, Las Vegas, NV

April 2008 “Naturals in Cosmetic Dermatology,” IX Chilean Congress of Dermatology, Viña del Mar, Chile “Photoaging and Its Prevention,” IX Chilean Congress of Dermatology, Viña del Mar, Chile “Fillers and the Perfect Lip,” IX Chilean Congress of Dermatology, Viña del Mar, Chile “Cosmetic Dermatology” during Roundtable, “What’s New in Dermatology,” IX Chilean Congress of Dermatology, Viña del Mar, Chile

February 2008 “The Basic Science of HA Fillers and Clinical Correlations,” American Academy of Dermatology Annual Meeting, San Antonio, TX “Differentiating between different HA fillers and Juvederm extension study data,” American Academy of Dermatology Annual Meeting, San Antonio, TX “Botox and Intense Pulsed Light (IPL) treatment,” Aging Gracefully Symposium, American Academy of Dermatology Annual Meeting, San Antonio, TX

January 2008 “The Art of Botox® and Fillers,” American Academy of Cosmetic Surgery Annual Meeting, Orlando, FL

Page ! of !36 50


November 2007 “Dermal Fillers and Skin Care,” 9th Conference of the GCC League of Dermatologists, Khobar, Saudi Arabia “Skin Care by Skin Type,” 9th Conference of the GCC League of Dermatologists, Khobar, Saudi Arabia “Skin Care of Sensitive Skin,” 9th Conference of the GCC League of Dermatologists, Khobar, Saudi Arabia “Treatment of Unwanted Pigmentation,” 9th Conference of the GCC League of Dermatologists, Khobar, Saudi Arabia

September 2007 “Aesthetics – Trends in the U.S.,” 21st World Congress of Dermatology, Buenos Aires, Argentina “How Photography Helps Your Practice,” 21st World Congress of Dermatology, Buenos Aires, Argentina “Dermatological Solutions to Skin Aging: A World in Transition,” 21st World Congress of Dermatology, Buenos Aires, Argentina “From Theory to Practice: Filler-Specific Injection Techniques for Optimizing Cosmetic Benefits to Your Patients” during Corrective and Aesthetic Dermatology Symposium, 21st World Congress of Dermatology, Buenos Aires, Argentina “Dermal Fillers” during Symposium on Dermatosurgery, 21st World Congress of Dermatology, Buenos Aires, Argentina “16 Skin Types” during Symposium on Aesthetic Dermatology, 21st World Congress of Dermatology, Buenos Aires, Argentina “Pathophysiology of Photoaging” during Symposium on Practical Pearls in Aesthetic Dermatology, 21st World Congress of Dermatology, Buenos Aires, Argentina Chair, Symposium on Aesthetic Dermatology, 21st World Congress of Dermatology, Buenos Aires, Argentina

May 2007 “Skin Care by Skin Type,” Italian Society of Dermatology, Capri, Italy

February 2007 “Hope in a Jar?,” Aging Gracefully Symposium, American Academy of Dermatology Annual Meeting, Washington, DC

January 2007 “Skin Care by Skin Type,” American Academy of Cosmetic Surgeons, Phoenix, AZ

November 2006 “Hyperhidrosis,” International Conference on Neurotoxins, Hollywood, FL

September 2006 Spoke to sales force at Juvéderm launch, Dallas, TX

Page ! of !37 50


July 2006 “Skin Care by Skin Type,” American Academy of Dermatology Summer Meeting, San Diego, CA

July 2006 Symposium Chair, “Skin Care Considerations in Ethnic Skin,” Cosmetic Symposium, San Diego, CA

June 2006 “Skin Care by Skin Type,” Royal College of Physicians, London, England

“Using Collagen and HA in Combination for the Treatment of the Aging Face,” Royal College of Physicians, London, England

June 2006 “Skin Care by Skin Type,” Royal College of Surgeons, Dublin, Ireland

March 2006 “Skin Care by Skin Type,” Oculoplastics 2006, Bascom Palmer Eye Institute, Miami, FL

“Dermal Fillers,” Oculoplastics 2006, Bascom Palmer Eye Institute, Miami, FL

March 2006 “Fillers,” American Academy of Dermatology Annual Meeting, San Francisco, CA

February 2006 “Dermal Fillers,” presentations to cosmetic physicians in Sydney, Brisbane, and Melbourne, Australia

January 2006 “Skin Care by Skin Type,” Featured Speaker, American Academy of Cosmetic Surgery Meeting, Orlando, FL

“Facial Rejuvenation,” American Academy of Cosmetic Surgery Meeting, Orlando, FL

November 2005 “Cosmeceuticals,” Presentation at the Italian Hospital, Buenos Aires, Argentina

“Skin Care by Skin Type,” Presentation at the Italian Hospital, Buenos Aires, Argentina

Page ! of !38 50


“Dermal Fillers,” Curso Intensivo de Perfeccionamiento Dermatologico para Graduados, Buenos Aires, Argentina

“Photoprotection,” Curso Intensivo de Perfeccionamiento Dermatologico para Graduados, Buenos Aires, Argentina

October 2005 “Evaluation of the Aging Face,” European Academy of Dermatology, London, England

August 2005 “Fillers: basics and complications,” International Meeting for Cosmeticians, “Prevention and therapy of skin aging,” Santiago, Chile

August 2005 “Approach to the aging skin,” XV International Therapeutic Meeting, “Prevention and management of cutaneous photo aging,” Santiago, Chile

“Cosmeceuticals,” XV International Therapeutic Meeting, “Prevention and management of cutaneous photo aging,” Santiago, Chile

“Fillers,” XV International Therapeutic Meeting, “Prevention and management of cutaneous photo aging,” Santiago, Chile

“Skin care science for dry and sensitive skin,” XV International Therapeutic Meeting, “Prevention and management of cutaneous photo aging,” Santiago, Chile

July 2005 “Dermal Fillers,” American Academy of Dermatology Summer Meeting, Chicago, IL

“Toxins and Fillers,” American Academy of Dermatology Summer Meeting, Chicago, IL

“Natural Ingredients in Cosmetics,” American Academy of Dermatology Summer Meeting, Chicago, IL

June 2005 “Dermal Fillers,” Korean Society of Cosmetic Dermatology, Seoul, Korea

“Skin Care by Type,” Korean Society of Cosmetic Dermatology, Seoul, Korea

June 2005 “Dermal Fillers,” Institute of Dermatology, Bangkok, Thailand

Page ! of !39 50


April 2005 “Skin Care by Type,” American Society of Aesthetic Plastic Surgery, New Orleans, LA

February 2005 Chair, Soft Tissue Augmentation course, American Academy of Dermatology Annual Meeting, New Orleans, LA

“New Generation of Hyaluronic Acid Fillers,” American Academy of Dermatology Annual Meeting, New Orleans, LA

“Hot Topics,” American Academy of Dermatology Annual Meeting, New Orleans, LA

“My Approach to Fillers and Toxins” American Academy of Dermatology Annual Meeting, New Orleans, LA

“Update on Hylaform and Cosmoplast,” American Academy of Dermatology Annual Meeting, New Orleans, LA

“What’s New in Cosmeceuticals,” American Academy of Dermatology Annual Meeting, New Orleans, LA

November 2004 “Cosmeceutical Ingredients,” European Society for Cosmetic and Aesthetic Dermatology, Florence, Italy

“New Dermal Fillers,” European Society for Cosmetic and Aesthetic Dermatology, Florence, Italy

“A Practical Approach to Cosmeceuticals,” European Society for Cosmetic and Aesthetic Dermatology, Florence, Italy

November 2004 Co-Chair of Session: “The Renaissance of Phlebology: Treatment of Microvessels in the United States,” European Academy of Dermatology and Venereology, Florence, Italy

September 2004 “Melasma and Its Treatment,” The Brazilian Congress of Dermatology, Natal, Brazil

“Comparison of Botulinum Toxin A (Botox) vs. Dysport,” The Brazilian Congress of Dermatology, Natal, Brazil

“Dermal Fillers,” The Brazilian Congress of Dermatology, Natal, Brazil

August 2004 “Fillers,” International Master Course on Aging Skin (IMCAS), Boston, MA

Page ! of !40 50


July 2004 “Cosmetics,” American Academy of Dermatology Summer Meeting, New York, NY

“Botulinum Toxin,” American Academy of Dermatology Summer Meeting, New York, NY

“Therapeutics,” American Academy of Dermatology Summer Meeting, New York, NY

February 2004 “Cosmoplast and Cosmoderm for Facial Rejuvenation,” American Academy of Dermatology Annual Meeting, Washington, DC

“New Dermal Fillers,” American Academy of Dermatology Annual Meeting, Washington, DC

“A Practical Approach to Cosmeceuticals,” American Academy of Dermatology Annual Meeting, Washington, DC

“The Perfect Lip,” American Academy of Dermatology Annual Meeting, Washington, DC

February 2004 “New Dermal Fillers,” Florida Society of Dermatology and Dermatologic Surgery, Miami Beach, FL

October 2003 “Myobloc for Axillary Hyperhidrosis,” American Society for Dermatologic Surgery, New Orleans, LA

“Cosmeceuticals,” American Society for Dermatologic Surgery, New Orleans, LA

“Botanical Modifiers in Cosmetics,” American Society for Dermatologic Surgery, New Orleans, LA

“Dermal Fillers”, American Society for Dermatologic Surgery, New Orleans, LA

October 2003 “Non Ablative Facial Rejuvenation,” International Congress of Esthetics, East 2003, Miami, FL

October 2003 “Winter Skin Care.” American Academy of Dermatology Meeting media event, New York, NY

September 2003 “Update on Dermal Fillers”, Annual Anti-Aging Symposium, Tokyo, Japan

Page ! of !41 50


September 2003 “Botulinum Toxin and Filler Materials for Facial Lines and Wrinkles,” American Academy of Otolaryngology, Orlando, FL

July 2003 “A Practical Approach to Cosmeceuticals,” American Academy of Dermatology Summer Meeting, Chicago, IL

“Novel Cosmeceutical Ingredients”, American Academy of Dermatology Summer Meeting, Chicago, IL

June 2003 “Comparison of Botulinum Toxins Types A, B, and E,” Advanced Combined Workshop Seminar, Paris, France

“Botox—My Technique in the Upper Face,” Advanced Combined Workshop Seminar, Paris, France

March 2003 “Green Tea and other Cosmeceuticals,” American Academy of Dermatology Annual Meeting, San Francisco, CA

“Cosmeceuticals: What Works and What Doesn’t,” American Academy of Dermatology Annual Meeting, San Francisco, CA

Director- Soft Tissue Augmentation Course. American Academy of Dermatology Annual Meeting, San Francisco, CA

February 2003 “Cosmeceuticals,” Florida Society of Dermatology & Dermatologic Surgery Symposium, Miami Beach, FL

February 2003 “Botulinum Toxins,” Medicis Winter Skin Seminar, Snowmass, CO

“Cosmeceuticals,” Medicis Winter Skin Seminar, Snowmass, CO

October 2002 “What’s New in Cosmetics,” Fall Clinical Dermatology Conference, Las Vegas, NV

August 2002 “Use of Botulinum Toxin Type B,” American Academy of Dermatology Summer Meeting, New York, NY

Page ! of !42 50


June 2002 “Botulinic Toxins A and B – Uses,” International Society of Dermatology Regional Meeting, Porto, Portugal

February 2002 “Cosmeceuticals, New and Emerging Therapies Symposium,” American Academy of Dermatology Annual Meeting, New Orleans, LA

“Clinical Use of Botulinum Toxins A and B for Cervical Dystonia,” American Academy of Dermatology Annual Meeting, New Orleans, LA

February 2002 Director, Soft Tissue Augmentation Course, American Academy of Dermatology Annual Meeting, New Orleans, LA

October 2001 “The Use of MYOBLOC™ for the Treatment of Facial Wrinkles,” American Society of Dermatology Surgery Annual Meeting, Dallas, TX

July 2001 “Treatment of Unwanted Facial Hair in Women,” American Academy of Nurse Practitioners Meeting, Orlando FL

March 2001 “Evidence Based Medicine and Cosmetic Dermatology,” American Academy of Dermatology Annual Meeting, Washington DC

December 2000 “Cosmetic Uses of Botox,” combined dermatology and plastic surgery meeting, Kuala Lumpur, Malaysia

December 2000 “Chemical Peels,” combined dermatology and plastic surgery meeting, Hong Kong

November 2000 “Cosmetic Uses of Botox,” combined dermatology and plastic surgery meeting, Singapore

Page ! of !43 50


August 2000 “What’s New in Cosmetic Dermatology?,” Therapeutics Session, American Academy of Dermatology Summer Meeting, Nashville, TN

“Setting Up a Cosmetic Dermatology Practice,” American Academy of Dermatology Summer Meeting, Nashville, TN

July 2000 “Cosmetic Concerns of Men and Women,” Family Practice Conference “Primary Care 2000,” Kiawa, SC

April 2000 Cosmetic Uses of Botox,” combined dermatology and plastic surgery meeting, Hong Kong

April 2000 Presented one press conference, 9 lectures and teaching sessions on the “Cosmetic Uses of Botox®,” speaker for Allergan, Taipei, Taichung, Tainen, and Kaohsiung, Taiwan

January 2000 “Superficial Chemical Peels,” Skin and Aging Meeting, Fort Lauderdale, FL

November 1999 “Chemical Peels, Botox and Soft Tissue Augmentation,” Anti-Aging Congress, Hong Kong

October 1999 “Cosmetic Uses of Botox,” speaker at “Institute of Dermatology”, Bangkok, Thailand

July 1999 “Workshops on Restylane, Botox, TCA 30% and AHA and BHA peels,” with M. Zaiac MD (Spanish), V Reunion Internacional De Terapéutica Dermatologica, Monterrey, Mexico

“How To Set Up a Cosmetic Practice” (English), V Reunion Internacional De Terapéutica Dermatológica, Monterrey, Mexico

“Toxina-Botulínica” (Spanish), V Reunión Internacional De Terapéutica Dermatológica, Monterrey, Mexico

Page ! of !44 50


Poster Exhibits

January 2018 Shridharani, SM., Humphrey, S., Dayan, SH., Baumann, L., Gallagher, CJ. “Personal and Social Impacts of Submental Fat in the US Population” IMCAS, Paris, France

June 1999 “Setting Up a Cosmetic Practice in An Academic Setting,” Cosmetic Dermatology-Increasing revenues for the Dermatology Practice Symposium, San Francisco, CA

May 1999 “The Treatment of Bovine Collagen Hypersensitivity with Oral Cyclosporin,” American Society of Dermatologic Surgery Meeting, Miami, FL

February 1999 “La Verdad Acerca de La Vitamina C” (Spanish), 50th anniversary Dermatology Society of the Dominican Republic, Santo Domingo, Dominican Republic

February 1999 “How to Start a Cosmetic Practice,” Dermatology Meeting, Broward County, FL

March 1998 “Cosmetic Dermatology – What are the Options?” (Spanish), via satellite presentation, Jornadas de Actualizaciones Terapéuticas Dermatológicas y Estéticas, Buenos Aires, Argentina

May 1996 “Double blinded placebo controlled trial examining the effects of Vitamin E on post operative surgical scars,” with J. Spencer, MD, American Society of Dermatologic Surgery Meeting, Palm Springs, CA

February 1996 “Recurrent Abscesses in Papillon - LeFevre Syndrome,” with R. Kerdel, MD, American Academy of Dermatology Gross and Microscopic Dermatology Conference, Miami, FL

Page ! of !45 50


January 2017 Humphrey, S., Dayan, SH., Shridharani, SM., Baumann, L., Gallagher, CJ. “Personal and Social Impacts of Submental Fat in the US Population,” The Winter Clinical Dermatology Conference, Kohala Coast, HI.

October 2016 Humphrey, S., Dayan, S., Shridharani, S.M., Baumann, L.,

Gallagher, C.J. “Personal and Social Impacts of Submental Fat in the US Population,” Fall Clinical Dermatology Conference, Las Vegas, Nevada

October 2016 Baumann, L., Goldberg, DJ., Stein-Gold, L., Tanghetti, EA., Lain, T., Kaufman, J., Berk, DR., Gurpreet A. “Efficacy and Safety of Topical Oxymetzoline Cream 1.0% for the Treatment of Facial Erythema Associated With Rosacea: Findings From the Second of 2 Pivotal Trials,” Fall Clinical Dermatology Conference, Las Vegas, Nevada

March 2008 Brandt F, Swanson N, Baumann L. “Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Reloxin® in the Treatment of Glabellar Lines,” Winter Clinical Dermatology Conference, Maui, Hawaii

September 2007 Baumann L, Grimes P, Pandya AG, Rendon M, Taylor S. “Triple combination cream is an effective treatment for post-inflammatory hyperpigmentation,” 21st World Congress of Dermatology, Buenos Aires, Argentina

February 2007 Baumann L, Grimes P, Pandya, AG, Rendon M. “Triple combination cream is an effective treatment for post-inflammatory hyperpigmentation,” American Academy of Dermatology Annual Meeting, Washington, DC

February 2007 Baumann LS, Thomas JA, Murphy DK, Walker PS. “Photographic documentation comparing long-term nasolabial fold correction with new hyaluronic acid fillers and crosslinked bovine collagen: Results from a multicenter, double-blind, randomized study,” American Academy of Dermatology Annual Meeting, Washington, DC

Page ! of !46 50


January 2007 Baumann LS, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, Walker PS. “Comparison of hyaluronic acid-based fillers and crosslinked bovine collagen: A double-masked, multicenter, randomized, within-subject study,” International Master Course on Aging Skin, Paris, France

January 2007 Baumann LS, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, Walker PS. “Comparison of hyaluronic-acid based fillers (JUVEDERM™) and crosslinked bovine collagen (ZYPLAST®): A double-masked, multicenter, randomized, within-subject study,” Winter Clinical Dermatology Conference—Hawaii, Kohala Coast, HI

October 2006 Baumann LS, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, Walker PS. “Comparison of JUVEDERM™ injectable gels and Zyplast® collagen implant: A double-masked, multicenter, randomized, within-subject study,” 25th Anniversary Fall Clinical Dermatology® Conference, Las Vegas, NV

July 2006 Baumann LS, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, Walker PS. “Comparison of Hyaluronic Acid-Based Fillers and Crosslinked Bovine Collagen: A Double-Masked, Multicenter, Randomized, Within-Subject Study,” American Academy of Dermatology Summer Meeting, San Diego, CA

March 2006 Baumann L, Shamban A, Lupo M, Monheit GD, Smith S, Frankel A, et. al. “Comparison of a Family of New Generation Hyaluronic Acid-Based Fillers with Crosslinked Bovine Collagen in the Correction of Nasolabial Folds: A Double-Masked, Multicenter, Randomized, Within-Subject Study,” American Academy of Dermatology Annual Meeting, San Francisco, CA

Page ! of !47 50


March 2006 Gendler E, Baumann L, Monheit G, Grimes P. “The Efficacy and Safety of Hylan B Viscoelastic Gel Implant as Compared to Glutaraldehyde Cross-linked Bovine Collagen Implants in Non-Caucasian Patients Undergoing Correction of Nasolabial Folds,” American Academy of Dermatology Annual Meeting, San Francisco, CA

February 2004 Baumann L, Rogers C, Welsh E, Frankel S, Martin LK, Black L, Bryde J. “A Single-Blinded Placebo-Controlled Clinical Trial Evaluating the Safety and Efficacy of Topical Anesthesia with dichlorotetrafluoroethane prior to Botulinum Toxin Type A Injections for Palmar Hyperhidrosis,” American Academy of Dermatology Annual Meeting, Washington DC

March 2003 Baumann L, Vujevich J, Halem M, Kerdel F, Pacheco H, Black L, Bryde J. “Pilot Study Using Alitretinoin Gel 0.1% for the Treatment of Photoaging,” American Academy of Dermatology Meeting, San Francisco, CA

July 2002 Baumann L, Slezinger A, Bryde J, Black L, Duncan R. “A Double-Blind, Randomized, Placebo-Controlled Pilot Study of the Safety and Efficacy of MYOBLOC™ (Botulinum Toxin, Type B) for the Treatment of Crow’s Feet Wrinkles,” World Congress of Dermatology, Paris, France

July 2002 Baumann L, Slezinger A, Bryde J, Black L, Duncan R. “A Double-Blind, Randomized, Placebo-Controlled Pilot Study of the Safety and Efficacy of MYOBLOC™ (Botulinum Toxin, Type B) for the Treatment of Axillary Hyperhidrosis,” World Congress of Dermatology, Paris, France

February 2002 Taylor S, Torok H, Jones T, Lowe N, Baumann L, Jarrat M, Martin D, Menter A, Pariser D, Rich P, Ramirez N, Shavin J, Tschen E, Weiss J, Wieder J. “Efficacy and Safety of a Triple Combination Agent for the Treatment of Facial Melasma,” American Academy of Dermatology Annual Meeting, New Orleans, LA

Page ! of !48 50


Media/Television Appearances

February 2002 Shah N, Lazarus M, Bugdodel R, Hsai S, He J, Duncan R, Baumann L. “The Effects of Topical Vitamin K on Post-Laser Treatment of Bruising,” American Academy of Dermatology Annual Meeting, New Orleans, LA

May 2001 Shah N, Lazarus M, Bugdodel R, Hsai S, He J, Duncan R, Baumann L. “The effects of topical Vitamin K on post laser treatment of bruising,” Society of Cosmetic Chemists, New Orleans, LA

September 1995 Baumann L, Kerdel F. “Treatment of Papillon - LeFevre Syndrome with Etretinate,” International Dermatologic Society meeting, Miami, FL

2010

April 2010

“The Skin Type Solution” PBS Special

“Today Tonight,” Australia.

June 2008 PBS Special, Indianapolis, IN.

June 2006 “The Skin Type Solution,” Ireland AM, Dublin, Ireland

April 2006 “The Skin Type Solution,” Today Show Australia. Sydney, Australia

March 2006 “The Skin Type Solution,” Canada AM, Toronto, Canada

March 2006 “The Skin Type Solution,” Breakfast TV Canada, Vancouver, Canada

March 2006 “Skin Care by Skin Type,” Good Morning America, New York, NY

Page ! of !49 50


SERVICE

September 2001 – 2009 UMMG Finance Committee University of Miami School of Medicine

September 2002 – 2004 Institutional Review Board Committee University of Miami School of Medicine

Page ! of !50 50

lb cv feb 2019 - derm.net fileleslie s. baumann md academic non-academic departmental administrative...

Documents